Literature DB >> 28413515

Outcome of out-of-hospital cardiac arrest after fibrinolysis with reteplase in comparison to the return of spontaneous circulation after cardiac arrest score in a geographic region without emergency coronary intervention.

Thomas Luiz1, Alexander Wilhelms1, Christian Madler1, Gregor Pollach1, Bernd Haaff2, Joachim Grüttner3, Tim Viergutz4.   

Abstract

Coronary occlusion and pulmonary embolism are responsible for the majority of cases of out-of-hospital cardiac arrest (OHCA). Despite previous favourable results of pre-hospital fibrinolysis in cases of OHCA, the benefit could not be confirmed in a large controlled study using the fibrinolytic tenecteplase. For reteplase (r-PA), there are hardly any data regarding pre-hospital fibrinolysis during ongoing resuscitation. The present study reported results using r-PA therapy in a German physician-supported Emergency Medical Services system. The data of OHCA patients who received pre-hospital fibrinolytic treatment with r-PA after an individual risk/benefit assessment were retrospectively analysed. To assess the effectiveness of this approach, the rate of patients with a return of spontaneous circulation (ROSC) was compared with the corresponding figure that was calculated with the help of the RACA (ROSC after cardiac arrest) score. The RACA algorithm predicts the probability of ROSC based on data from the German Resuscitation Registry. Further outcome data comprised hospital discharge rate and neurologic status at discharge. From 2001 to 2009, 43 patients (mean age, 58.5 years; 65.1% male; 58.1% ventricular fibrillation) received r-PA. Of these, 20 patients (46.5%) achieved ROSC, compared to a probability of 49.8% according to the RACA score (P=0.58). A total of 8 patients (18.6%) were discharged alive, including 5 (11.2%) with a good neurological outcome. For the analysed small patient collective, pre-hospital r-PA did not offer any benefits with regard to the ROSC rate. Further analyses of larger patient numbers on a nationwide registry basis are recommended.

Entities:  

Keywords:  cardiopulmonary resuscitation; emergency medical services; fibrinolysis; out-of-hospital cardiac arrest; reteplase

Year:  2017        PMID: 28413515      PMCID: PMC5377519          DOI: 10.3892/etm.2017.4155

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  32 in total

1.  Comparison of computed tomography and autopsy in detection of injuries after unsuccessful cardiopulmonary resuscitation.

Authors:  David Smekal; Tomas Hansen; Håkan Sandler; Sten Rubertsson
Journal:  Resuscitation       Date:  2012-07-06       Impact factor: 5.262

Review 2.  European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support.

Authors:  Jerry P Nolan; Charles D Deakin; Jasmeet Soar; Bernd W Böttiger; Gary Smith
Journal:  Resuscitation       Date:  2005-12       Impact factor: 5.262

3.  A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents.

Authors:  Xin Li; Qing-ling Fu; Xiao-li Jing; Yu-jie Li; Hong Zhan; Zhong-fu Ma; Xiao-xing Liao
Journal:  Resuscitation       Date:  2006-06-09       Impact factor: 5.262

4.  Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest.

Authors:  W Lederer; C Lichtenberger; C Pechlaner; G Kroesen; M Baubin
Journal:  Resuscitation       Date:  2001-07       Impact factor: 5.262

5.  The platelet-related effects of tenecteplase versus alteplase versus reteplase.

Authors:  Paul A Gurbel; Kevin Hayes; Kevin P Bliden; Jason Yoho; Udaya S Tantry
Journal:  Blood Coagul Fibrinolysis       Date:  2005-01       Impact factor: 1.276

6.  Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest.

Authors:  S Gando; T Kameue; S Nanzaki; Y Nakanishi
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

7.  Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.

Authors:  Riyad B Abu-Laban; James M Christenson; Grant D Innes; Catherina A van Beek; Karen P Wanger; R Douglas McKnight; Iain A MacPhail; Joe Puskaric; Richard P Sadowski; Joel Singer; Martin T Schechter; Victor M Wood
Journal:  N Engl J Med       Date:  2002-05-16       Impact factor: 91.245

8.  Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.

Authors:  P A Gurbel; V L Serebruany; A R Shustov; R D Bahr; C Carpo; E M Ohman; E J Topol
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

9.  Platelet factor 4 release in patients undergoing cardiopulmonary resuscitation--can reperfusion be impaired by platelet activation?

Authors:  B W Böttiger; H Böhrer; T Böker; J Motsch; M Aulmann; E Martin
Journal:  Acta Anaesthesiol Scand       Date:  1996-05       Impact factor: 2.105

Review 10.  Incidence, predisposing factors, management and survival following cardiac arrest due to subarachnoid haemorrhage: a review of the literature.

Authors:  Markus B Skrifvars; Michael J Parr
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-11-14       Impact factor: 2.953

View more
  1 in total

1.  Comparison of urokinase and reteplase thrombolytic treatment in patients with high-risk pulmonary embolism.

Authors:  Yi Zhang; Lan Ma; Qi Fu; Tao Zhao; Rui-Ying Yan; Xing Su
Journal:  Exp Ther Med       Date:  2019-10-31       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.